Joyzyme Group Limited
Research Joyzyme Group Limited (8622.HK) on Bullrun: market cap HKD 91.75M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker8622.HK
- ExchangeHK
- CountryHong Kong
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyHKD
- Market capHKD 91.75M
- Financial periodFY2025
- RevenueCNY 28.28M
- Revenue growth11.5%
- Net income-CNY 5.01M
- Free cash flow-CNY 3.90M
- Gross margin62.8%
Valuation Snapshot
latest market cap is HKD 91.75M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 28.28M | -CNY 5.01M | -CNY 3.90M | 62.8% | -0.01 | CNY 36.94M | CNY 4.96M | CNY 51.13M |
| FY2024 | CNY 25.36M | -CNY 4.16M | -CNY 5.05M | 67.3% | -0.01 | CNY 31.50M | CNY 1.18M | CNY 54.05M |
| FY2023 | CNY 24.63M | -CNY 5.78M | -CNY 1.55M | 65.3% | -0.01 | CNY 32.94M | CNY 5.14M | CNY 51.02M |
| FY2022 | CNY 25.33M | -CNY 3.08M | CNY 475.00K | 66.8% | -0.01 | CNY 33.30M | CNY 1.88M | CNY 56.52M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 91.75M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 HKD.
About Joyzyme Group Limited
Joyzyme Group Limited, an investment holding company, engages in the research, production, and sale of male fertility in-vitro diagnostic (IVD) reagents in the People's Republic of China. The company provides biological reagents, including male fertility IVD reagents, parasite antibody detection reagents, and Epstein-Barr virus antibody detection reagent; healthcare products and supplements; and auxiliary reproductive supplies and equipment.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Joyzyme Group Limited's market cap?
Joyzyme Group Limited's market capitalization is HKD 91.75M.
What does Joyzyme Group Limited do?
Joyzyme Group Limited, an investment holding company, engages in the research, production, and sale of male fertility in-vitro diagnostic (IVD) reagents in the People's Republic of China. The company provides biological reagents, including male fertility IVD reagents, parasite antibody detection reagents, and Epstein-Barr virus antibody detection reagent; healthcare products and supplements; and auxiliary reproductive supplies and equipment. The company sells its products directly to hospitals and medical institutions, as well as to distributors.